We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Philips Introduces Next-Generation Digital Pathology Solution with Integrated AI Tools and Algorithms

By LabMedica International staff writers
Posted on 18 Oct 2021
Print article
Image: Philips Pathology Scanner (Photo courtesy of Royal Philips)
Image: Philips Pathology Scanner (Photo courtesy of Royal Philips)

Royal Philips (Amsterdam, the Netherlands) has launched its next-generation digital pathology solution, moving digital pathology into the heart of enterprise-wide healthcare informatics.

Precision medicine has increased the volume and complexity of workloads, with pathology labs worldwide facing a shortage of skilled staff. Within the diagnosis and staging of cancer, pathology information is combined with data from multiple disciplines, including radiology, pathology and genomics, to deliver the diagnostic precision required for highly personalized care. There is an urgent need for solutions that combine operational efficiency, team-working, expertise sharing, and enterprise-wide informatics to make the most of a pathology lab’s human resources.

Through breakthrough innovations and partnerships, Philips integrates intelligence and automation into its Precision Diagnosis portfolio, including smart diagnostic systems, integrated workflow solutions with the aim to transform departmental operations, advanced informatics that enhance diagnostic confidence, and care pathway solutions that allow medical professionals to tailor treatment to individual patients. By developing and integrating AI-enabled applications, the company aims to enhance the ability to turn data into actionable insights and drive the right care in the right sequence at the right time.

Philips Digital Pathology Suite - IntelliSite - features a comprehensive, scalable suite of software tools and capabilities designed to help streamline workflows, enhance diagnostic confidence, facilitate team collaboration, integrate artificial intelligence (AI) and increase the efficiency of pathology labs. Philips Digital Pathology Suite offers a range of solutions designed for different use cases with an affordable cost of ownership. From low-volume ‘spoke’ labs or small independent labs, where small batches of slides are continually processed and scanned, to medium and large labs operating high-volume batch processing workflows. The hardware is also pre-equipped for multi-layer slide scanning. Images are captured in a centralized informatics platform that has been optimized around pathologists’ workflows, integrating with leading third-party AI tools and algorithms with the aim to further reduce laboratory costs and enhance diagnostic capabilities.

Digital Pathology Suite includes a range of three pathology slide scanners, as well as Pathology Workspace - Image Management System - a comprehensive set of software tools and capabilities that encompass every stage of the digital pathology process, including an advanced image management system, bidirectional interoperability into laboratory information systems, and a case viewer that facilitates multidisciplinary case reviews and care pathway selection. Diagnostic confidence is enhanced by superb image quality and advanced algorithms, such as automatic tissue shape detection and non-rectangular optimization of regions of interest. Vendor-agnostic data interoperability also allows the easy sharing of patient-centric histology data across enterprises and between sites.

"Integrated diagnostic capabilities are a cornerstone to a precise diagnosis and personalized care pathway selection for oncology patients and only when data and specialties work together in harmony can the ultimate promise of care be realized,” said Louis Culot, General Manager Oncology Informatics at Philips. “That’s why bringing together multiple pieces of the healthcare continuum – like radiology, pathology, and genomics – is the key to a new paradigm of diagnostic precision. By providing pathologists the interoperability and connectivity to share high-quality images and diagnostic insights across networks, Philips Digital Pathology Suite positions them as key stakeholders in the data-driven healthcare systems of the future.”

Related Links:
Royal Philips 

Gold Supplier
Hemostasis Analyzer
STA R Max 3
New
6-Channel Viscoelastometry Analyzer
ClotPro
New
Lateral Flow Test Cassette Reader
Quantum Blue III
New
Flu A/B Antibodies and Antigens
HyTest Flu A/B Antibodies and Antigens

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.